financetom
Business
financetom
/
Business
/
Pfizer going 'all in' on obesity drug development, CEO Bourla says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Jan 13, 2025 11:10 AM

Jan 13 (Reuters) - U.S. drugmaker Pfizer ( PFE ) is going "all in" to develop its

experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive

Officer Albert Bourla said at the JPMorgan Healthcare conference on Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Asbury Automotive Accelerates Expansion With $1.34 Billion Herb Chambers Takeover
Asbury Automotive Accelerates Expansion With $1.34 Billion Herb Chambers Takeover
Feb 18, 2025
Asbury Automotive Group Inc ( ABG ) shares are trading lower on Tuesday. The company inked a deal to acquire The Herb Chambers Companies in a $1.34 billion deal. The transaction covers Herb Chambers’ 33 dealerships, 52 franchises, and three collision centers, representing $2.9 billion in 2024 revenue. The transaction, expected to close in the late second quarter of 2025, is subject to customary conditions...
National Bank Previews Canadian Banks' Q1
National Bank Previews Canadian Banks' Q1
Feb 18, 2025
12:31 PM EST, 02/18/2025 (MT Newswires) -- Canadian banks begin reporting first-quarter results on Feb. 25. The first-quarter reporting season comes with with far greater economic uncertainty than expected, National Bank writes. Attention will shift to bank guidance commentary, specifically related to credit (e.g., becoming more conservative) and revenue growth. Still, National Bank expects strong performance from Capital Markets segments....
Looking At Meta Platforms's Recent Unusual Options Activity
Looking At Meta Platforms's Recent Unusual Options Activity
Feb 18, 2025
Deep-pocketed investors have adopted a bearish approach towards Meta Platforms ( META ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in META usually suggests something big is about to happen. We gleaned this information...
Mckesson Insider Sold Shares Worth $5,382,514, According to a Recent SEC Filing
Mckesson Insider Sold Shares Worth $5,382,514, According to a Recent SEC Filing
Feb 18, 2025
12:34 PM EST, 02/18/2025 (MT Newswires) -- Brian S. Tyler, Director, Chief Executive Officer, on February 14, 2025, sold 8,961 shares in Mckesson (MCK) for $5,382,514. Following the Form 4 filing with the SEC, Tyler has control over a total of 69,840 common shares of the company, with 69,625 shares held directly and 215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/927653/000106299325002654/xslF345X05/form4.xml Price:...
Copyright 2023-2025 - www.financetom.com All Rights Reserved